Financial News
Axcella's new long COVID medication helps some patients in small trial
August 02, 2022 at 09:43 AM EDT
Clinical trials of a new drug aimed at tackling symptoms of long COVID, made by Axcella, show that the drug worked in helping some patients overcome their fatigue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
